LabGenius Revenue and Competitors
Estimated Revenue & Valuation
- LabGenius's estimated annual revenue is currently $6.1M per year.
- LabGenius's estimated revenue per employee is $100,500
- LabGenius's total funding is $28.7M.
Employee Data
- LabGenius has 61 Employees.
- LabGenius grew their employee count by 3% last year.
LabGenius's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Founder | Reveal Email/Phone |
2 | Head Finance | Reveal Email/Phone |
3 | VP People | Reveal Email/Phone |
4 | Head Antibody Engineering | Reveal Email/Phone |
5 | Director | Reveal Email/Phone |
6 | Project Manager | Reveal Email/Phone |
7 | Laboratory Manager | Reveal Email/Phone |
8 | Finance & Operations Manager | Reveal Email/Phone |
9 | Laboratory Manager III | Reveal Email/Phone |
10 | Assistant Laboratory Operations Manager | Reveal Email/Phone |
LabGenius Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $58.9M | 293 | 6% | N/A | N/A |
#2 | $21.1M | 105 | 5% | N/A | N/A |
#3 | $113.4M | 564 | 1% | N/A | N/A |
#4 | $20.9M | 104 | -5% | N/A | N/A |
#5 | $37M | 184 | 9% | N/A | N/A |
#6 | $45.4M | 226 | -24% | N/A | N/A |
#7 | $16.1M | N/A | N/A | N/A | |
#8 | $69.7M | 347 | 0% | N/A | N/A |
#9 | $8M | 40 | 3% | N/A | N/A |
#10 | $25.5M | 127 | 28% | N/A | N/A |
What Is LabGenius?
LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVA™). Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology and robotics.
keywords:Machine Learning, Synthetic Biology, Artificial Intelligence, Drug Discovery
$28.7M
Total Funding
61
Number of Employees
$6.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
LabGenius News
Founded in 2012, LabGenius is a venture-backed company that develops antibody treatments for cancer and inflammatory diseases by leaning on...
LabGenius is currently focused on discovering new treatments for cancer and inflammatory diseases. The firm combines AI, lab automation, and...
With over 30 years of industry experience, the former Global Head of Licensing at Servier Group will spearhead LabGenius’ business development, commercial strategy, and operational delivery. LONDON–(BUSINESS WIRE)–September 22, 2021– LabGenius, the machine learning (ML)-driven protein engineer ...
Join executive leaders at the Conversational AI & Intelligent AI Assistants Summit, presented by Five9. Watch now! Multi-year collaboration where LabGenius will apply its ML-driven protein engineering platform, EVATM, to the optimization of therapeutic NANOBODY® proteins LONDON–(BUSINESS WIRE) ...
London-based LabGenius, a biotech company using machine learning to develop new therapeutics, has secured a $15 million extension of its Series A, bringing the round’s total to $25 million. Atomico led the investment, and partner Irina Haivas will join the startup’s board. Other investors includ ...
Other Companies in Southwark
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.1M | 83 | -1% | N/A |
#2 | $3.5M | 95 | 9% | N/A |
#3 | $28.4M | 105 | 3% | N/A |
#4 | $15M | 112 | 1% | N/A |
#5 | $32.8M | 131 | -20% | N/A |